SAN FRANCISCO Aug. 3 2016 PRNewswire Nektar Therapeutics Nasdaq NKTR today reported its financial results for the second quarter ended June 30 2016. Cash and investments in marketable securities at June 30 2016 were $274.9 million as compared to $308.9 mi...
↧